Edition:
United States

NewLink Genetics Says Merck Has Begun Rolling Submission Of Licensure Application For Ebola Vaccine V920


Thursday, 15 Nov 2018 09:03am EST 

Nov 15 (Reuters) - NewLink Genetics Corp ::NEWLINK GENETICS ANNOUNCES MERCK HAS BEGUN ROLLING SUBMISSION OF LICENSURE APPLICATION FOR EBOLA VACCINE V920 (RVSV∆G-ZEBOV-GP) TO U.S. FOOD AND DRUG ADMINISTRATION.NEWLINK GENETICS - ROLLING SUBMISSION IS MADE PURSUANT TO FDA'S BREAKTHROUGH THERAPY DESIGNATION FOR V920.